Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139,816 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Generation of a humanized afucosylated BAFF-R antibody with broad activity against human B-cell malignancies.
Dong Z, Song JY, Thieme E, Anderson A, Oh E, Cheng WA, Kuang BZ, Lee V, Zhang T, Wang Z, Szymura S, Smith DL, Zhang J, Nian W, Zheng X, He F, Zhou Q, Cha SC, Danilov AV, Qin H, Kwak LW. Dong Z, et al. Among authors: wang z. Blood Adv. 2023 Mar 28;7(6):918-932. doi: 10.1182/bloodadvances.2022008560. Blood Adv. 2023. PMID: 36469551 Free PMC article.
A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma.
Qazilbash MH, Saini NY, Cha SC, Wang Z, Stadtmauer EA, Baladandayuthapani V, Lin H, Tross B, Honhar M, Rao SS, Kim K, Popescu M, Szymura S, Zhang T, Anderson A, Bashir Q, Shpall EJ, Orlowski RZ, Levine BL, Kerr N, Garfall A, Cohen A, Vogl DT, Dengel K, June CH, Champlin R, Kwak LW. Qazilbash MH, et al. Among authors: wang z. Blood. 2022 Mar 3;139(9):1289-1301. doi: 10.1182/blood.2020008493. Blood. 2022. PMID: 34521108 Free PMC article. Clinical Trial.
CD19/BAFF-R dual-targeted CAR T cells for the treatment of mixed antigen-negative variants of acute lymphoblastic leukemia.
Wang X, Dong Z, Awuah D, Chang WC, Cheng WA, Vyas V, Cha SC, Anderson AJ, Zhang T, Wang Z, Szymura SJ, Kuang BZ, Clark MC, Aldoss I, Forman SJ, Kwak LW, Qin H. Wang X, et al. Among authors: wang z. Leukemia. 2022 Apr;36(4):1015-1024. doi: 10.1038/s41375-021-01477-x. Epub 2022 Jan 18. Leukemia. 2022. PMID: 35039637 Free PMC article.
First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma.
Kwak L, Szymura S, Wang L, Zhang T, Cha SC, Dong Z, Anderson A, Oh E, Lee V, Wang Z, Parshottham S, Rao S, Olsem J, Crumpton B, Lee H, Manasanch E, Neelapu S, Thomas S. Kwak L, et al. Among authors: wang l, wang z. Res Sq [Preprint]. 2023 Sep 21:rs.3.rs-3315017. doi: 10.21203/rs.3.rs-3315017/v1. Res Sq. 2023. Update in: Nat Commun. 2024 Aug 11;15(1):6874. doi: 10.1038/s41467-024-50880-2. PMID: 37790486 Free PMC article. Updated. Preprint.
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial.
Szymura SJ, Wang L, Zhang T, Cha SC, Song J, Dong Z, Anderson A, Oh E, Lee V, Wang Z, Parshottam S, Rao S, Olsem JB, Crumpton BN, Lee HC, Manasanch EE, Neelapu S, Kwak LW, Thomas SK. Szymura SJ, et al. Among authors: wang l, wang z. Nat Commun. 2024 Aug 11;15(1):6874. doi: 10.1038/s41467-024-50880-2. Nat Commun. 2024. PMID: 39128904 Free PMC article. Clinical Trial.
Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells.
Jia Y, Han L, Ramage CL, Wang Z, Weng CC, Yang L, Colla S, Ma H, Zhang W, Andreeff M, Daver N, Jain N, Pemmaraju N, Bhalla K, Mustjoki S, Zhang P, Zheng G, Zhou D, Zhang Q, Konopleva M. Jia Y, et al. Among authors: wang z. Haematologica. 2023 Oct 1;108(10):2626-2638. doi: 10.3324/haematol.2022.281915. Haematologica. 2023. PMID: 37078252 Free PMC article.
139,816 results
You have reached the last available page of results. Please see the User Guide for more information.